Sapient Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Buy
128,573
+420
+0.3% +$9.71K 0.04% 131
2026
Q1
$3.07M Sell
128,153
-2,296
-2% -$56.1K 0.05% 131
2025
Q4
$2.97M Sell
130,449
-4,310
-3% -$93.8K 0.04% 133
2025
Q3
$2.64M Buy
134,759
+7,040
+6% +$118K 0.04% 132
2025
Q2
$1.82M Sell
127,719
-8,358
-6% -$97.7K 0.03% 146
2025
Q1
$1.43M Sell
136,077
-3,269
-2% -$37K 0.03% 167
2024
Q4
$1.69M Sell
139,346
-786
-0.6% -$10.3K 0.03% 154
2024
Q3
$2.06M Hold
140,132
0.04% 141
2024
Q2
$2.02M Sell
140,132
-83
-0.1% -$1.33K 0.04% 127
2024
Q1
$2.28M Sell
140,215
-156
-0.1% -$2.44K 0.05% 127
2023
Q4
$2.09M Buy
+140,371
New +$1.59M 0.05% 126

Other funds holding ELAN

Sapient Capital's ELAN Position: Q2 2026 in Review

Sapient Capital increased its Elanco Animal Health (ELAN) stake by 0.33% in Q2 2026, buying an estimated $9.71K and bringing the position to 128,573 shares worth $3.16M. The position accounts for 0.04% of the portfolio, ranked #131.

Sapient Capital first reported a position in ELAN in Q4 2023 and has held it in 11 quarters since. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Sapient Capital held 128,573 shares of Elanco Animal Health worth $3.16M as of Q2 2026.
  • Sapient Capital bought 420 Elanco Animal Health shares in Q2 2026, an estimated $9.71K.
  • Elanco Animal Health made up 0.04% of Sapient Capital's portfolio in Q2 2026, its #131 holding.
  • Sapient Capital first reported a position in Elanco Animal Health in Q4 2023 and has held it in 11 quarters since.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.